Ryght AI Partners with Global CRO Biorasi to Deliver AI-Powered Feasibility Solutions to Biotech and Biopharma Sponsors

Ryght AI Partners with Global CRO Biorasi to Deliver AI-Powered Feasibility Solutions to Biotech and Biopharma Sponsors

Advanced AI Platform Enables More Accurate Site Selection and Faster Study Startup Across Key Therapeutic Areas

Ryght AI Announces Partnership with Biorasi to Transform Feasibility Accuracy in Clinical Trials

What You Should Know: – Ryght AI, a leading AI clinical trial developer, today announced a partnership with Biorasi, a global clinical research organization (CRO) specializing in dermatology, oncology, neurology, and nephrology studies. – The collaboration will bring advanced, AI-driven feasibility capabilities to biotech and biopharma sponsors.  Ryght AI and Biorasi Partner to Redefine Clinical Trial Feasibility with AI Digital Twin Technology …